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Abstract
Peptide nucleic acid ﬂuorescence in situ hybridization (PNA FISH) is a molecular diagnostic tool for the rapid detection of pathogens directly
from liquid media. The aim of this study was to prospectively evaluate PNA FISH assays in comparison with culture-based matrix-assisted laser
desorption/ionization-time of ﬂight mass spectrometry (MALDI-TOF MS) identiﬁcation, as a reference method, for both blood and
cerebrospinal ﬂuid (CSF) cultures, during a 1-year investigation. On the basis of the Gram stain microscopy results, four different PNA FISH
commercially available assays were used (‘Staphylococcus aureus/CNS’, ‘Enterococcus faecalis/OE’, ‘GNR Trafﬁc Light’ and ‘Yeasts Trafﬁc Light’
PNA FISH assays, AdvanDx). The four PNA FISH assays were applied to 956 positive blood cultures (921 for bacteria and 35 for yeasts) and 11
CSF cultures. Among the 921 blood samples positive for bacteria, PNA FISH gave concordant results withMALDI-TOFMS in 908/921 (98.64%)
samples, showing an agreement of 99.4% in the case of monomicrobial infections. As regards yeasts, the PNA FISH assay showed a 100%
agreementwith the result obtained byMALDI-TOFMS.When PNAFISH assayswere tested on the 11CSF cultures, the results agreedwith the
reference method in all cases (100%). PNA FISH assays provided species identiﬁcation at least one work-day before the MALDI-TOF MS
culture-based identiﬁcation. PNA FISH assays showed an excellent efﬁcacy in the prompt identiﬁcation of main pathogens, yielding a signiﬁcant
reduction in reporting time and leading to more appropriate patient management and therapy in cases of sepsis and severe infections.
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Introduction
Rapid detection and identiﬁcation of microorganisms in blood
specimens have been advocated in order to shorten the
turnaround time (TAT) for appropriate management of patients
suffering from bacteraemia and fungaemia [1–3]. While the
automated, continuously monitoring blood culture (BC) sys-
tems have reduced the delay in detecting the presence of
blood-borne bacteria and fungi, identiﬁcation of such microor-
ganisms still requires subculturing the microorganism onto solid
media [4,5]. At present, different techniques for microorganism
identiﬁcation from positive BCs, such as real-time PCR, DNA
microarrays, matrix-assisted laser desorption/ionization-time of
ﬂight mass spectrometry (MALDI-TOF MS) and peptide nucleic
acid ﬂuorescence in situ hybridization (PNA FISH), are available
to shorten the TAT for the detection of Gram-positive cocci
(GPC), Gram-negative rods (GNR) and Candida spp. [6–10].
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Peptide nucleic acid ﬂuorescence in situ hybridization is a
molecular technology that rapidly identiﬁes directly from liquid
cultures the bacteria and yeasts most frequently responsible for
bloodstream infections [7,11,12]. In recent years the MAL-
DI-TOFMS has emerged as a powerful tool formicrobial species
identiﬁcation after they have grown on solid media [13–17].
To date, studies utilizing PNA FISH assays have been
reported for the detection of GPC, Candida spp. and GNR,
separately [1,18–22] or in comparison with standard culture
methods [7]. The aim of the present study was to prospec-
tively compare PNA FISH assays with culture-based MAL-
DI-TOF MS for the identiﬁcation of bacteria and yeasts in
positive BCs in a clinical routine setting. The second aim was
to evaluate the identiﬁcation accuracy of the PNA FISH assays
from cerebrospinal ﬂuids (CSF) inoculated into BC media.
Materials and Methods
Patients and clinical samples
From January to December 2012, 12 051 BCs collected from
4713 patients (2104 female and 2609male; median age 68 years,
range 1 day–101 years) with clinical suspicion of sepsis or other
severe infections, such as endocarditis, pneumonia ormeningitis,
were routinely sent to the Bacteriology Section of the Unit of
Clinical Microbiology of the University Hospital of Parma for the
diagnosis of bacterial infections. Among the 1907 positive BCs
(belonging to 1114 patients), 921 samples (belonging to 886
patients) were selected for the PNA FISH assays. The PNA FISH
assays were generally performed on the ﬁrst sample of each
patient; they were eventually repeated in samples of the same
patient following the ﬁrst one if the Gram stain result was
different from that of the ﬁrst sample or in samples collected at
least 15 days from the ﬁrst one. This was in order to check
whether the same or a new microorganism was involved in a
second episode of sepsis.
If a set of BCs from a patient (aerobic plus anaerobic
bottles) was positive, a single bottle was evaluated (the ﬁrst
that tested positive).
In the same period, 35 (belonging to 34 patients) of the 138
positive samples (belonging to 55 patients) were selected for
Candida spp. PNA FISH assay, following the same criteria as for
bacteria. The 138 positive samples were obtained from 3740
blood samples collected from 1194 patients (544 female and
650 male; median age 68 years, range 1 day–99 years) with
clinical suspicion of fungaemia and routinely sent to the
Mycology Section of the above-mentioned Unit of Clinical
Microbiology.
Among the 410 samples of CSF (belonging to 197 patients;
88 female and 109 male; median age 49 years, range 1 day–
91 years) routinely examined during 2012, a panel of 11
positive BC bottles inoculated with CSF (belonging to 11
patients) was selected, as described above for bacterial BCs,
for the PNA FISH assays from 45 positive samples (belonging
to 27 patients). These patients presented with hydrocephalus,
clinical suspicion of central nervous system infection (menin-
gitis and encephalitis) or polytrauma involving the central
nervous system.
The samples analysed in this study were sent to the
University Hospital of Parma for routine diagnostic purposes,
and the laboratory diagnosis results were reported in the
medical records of the patients as a diagnostic answer to a
clinical suspicion of sepsis; ethical approval at the University
Hospital of Parma is required only in cases in which the clinical
samples are to be used for applications other than diagnosis.
Conventional blood/cerebrospinal ﬂuid culture processing
and reference method for identiﬁcation from solid culture
Blood and CSF cultures were screened for microbial growth
with the Bactec FX system (Becton Dickinson, Sparks, MD,
USA), using BACTEC Plus Aerobic F, Plus Anaerobic F, Plus
Ped and Mycosis IC/F bottles (Becton Dickinson) according to
standard methods and to the manufacturer’s recommenda-
tions [23]. As part of a routine culture set for bacterial
detection, 8–10 mL of blood were inoculated into each
aerobic and anaerobic bottle, and incubated at 37°C; for yeast
detection Mycosis IC/F bottles were used. In the case of CSF
samples, in parallel with conventional culture on solid media,
an aliquot (1–3 mL) was inoculated into a Bactec Plus Ped
bottle. When a bottle signalled positive by the Bactec FX
instrument a Gram stain was performed and an aliquot was
subcultured onto blood agar, MacConkey agar, Schaedler agar
and/or Sabouraud dextrose agar with chloramphenicol (KIMA,
Piove di Sacco-PD, Italy) and incubated at 37°C in the
appropriate conditions according to bottle type and Gram
staining result. After sufﬁcient (at least two to three colonies)
pure microbial growth was achieved (24–72 h), identiﬁcation
tests were performed by a Microﬂex LT- MALDI Biotyper
mass spectrometer (Bruker Daltonics GmbH, Bremen, Ger-
many, supplied by Becton Dickinson, Italy) in the case of
Gram-negative bacteria and by a VITEK MS mass spectrometer
(bioMerieux, Marcy L’Etoile, France) in the case of Gram-po-
sitive bacteria and yeasts, according to the laboratory work-
ﬂow.
Matrix-assisted laser desorption/ionization-time of ﬂight
mass spectrometry
Matrix-assisted laser desorption/ionization-time of ﬂight mass
spectrometry was performed according to the manufacturer’s
instructions. A single bacterial colony of fresh overnight
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culture was smeared directly in duplicate onto a ‘MSP-96
polished steel’ target plate (Bruker Daltonics) or onto a
polymeric target slide (VITEK MS-DS; bioMerieux) and cov-
ered with 1 lL of matrix, a saturated solution of a-cyano-4--
hydroxy cinnamic acid (Bruker Daltonics) in 50% acetonitrile
with 2.5% triﬂuoracetic acid (Sigma-Aldrich, Milan, Italy) for
the MALDI Biotyper method or a-cyano-4-hydroxy cinnamic
acid in acetonitrile/ethanol/water 1:1:1–3% triﬂuoracetic acid
(bioMerieux) for the VITEK MS method. The plate was then
left to dry at room temperature for 5 min. For yeasts, before
applying the matrix solution, 1 lL of formic acid (VITEK
MS-FA; bioMerieux) was added to the plate and air dried for
5 min.
For the Microﬂex LT mass spectrometer (Bruker Daltonics)
system, in each plate Escherichia coli (Bruker Bacterial Test
Standard, Bruker Daltonics) was used as a positive control. For
MALDI-TOF VITEK MS, each plate was calibrated and
validated with a control strain of E. coli (ATCC 8739) tested
at the beginning and at the end of the use of each plate. For
both Microﬂex LT and the VITEK MS system, the spectra were
automatically obtained in the linear positive mode within a
mass range from 2000 to 20 000 Da and analysed by the
FlexControl software (version 3.3.63; Bruker Daltonics) and
the Myla software (version 3.1.0–15; bioMerieux), respectively.
Peptide nucleic acid ﬂuorescence in situ hybridization assays
On the basis of the Gram stain microscopy result (from the
positive blood/CSF culture bottles), four different probe sets
for PNA FISH (AdvanDx, Woburn, MA, USA) were used
according to manufacturer’s instructions: ‘Staphylococcus aur-
eus/CNS PNA FISH’ (afterwards named as SA) in the case of
samples containing GPC in pairs or clusters for the identiﬁ-
cation and differentiation of S. aureus (appearing with a green
ﬂuorescence) and coagulase-negative staphylococci (CNS)
(red), ‘Enterococcus faecalis/OE PNA FISH’ (EF) in the case of
GPC in chains identifying E. faecalis (green) and other entero-
cocci (red), ‘GNR Trafﬁc Light PNA FISH’ (GNTL) for GNR
distinguishing E. coli (green), Klebsiella pneumoniae (yellow) and
Pseudomonas aeruginosa (red) and ‘Yeasts Trafﬁc Light PNA
FISH’ (YTL) for yeasts distinguishing Candida albicans/Candida
parapsilosis (green), Candida tropicalis (yellow) and Candida
glabrata/Candida krusei (red).
Brieﬂy, a drop of liquid culture placed on a microscope slide
was ﬁxed for 20 min at 55°C, hybridized with a drop of the
speciﬁc PNA probe for 30 min at 55°C and washed for
30 min. Slides were examined at 1009 on a ﬂuorescent
microscope equipped with a dual band ﬁlter. Probe-speciﬁc
PNA FISH positive and negative control slides were obtained
from the manufacturer and utilized for quality control each
time the PNA FISH assay was performed.
A PNA FISH result was considered concordant or discor-
dant with that obtained by culture-based MALDI-TOF MS,
taking into account the species detectable by PNA probes. A
negative result by PNA FISH was considered concordant with
MALDI-TOF MS when the species identiﬁed was not included
in the spectrum of those recognized by PNA probes.
Reference bacterial and yeast strains
To assess the detection limit of each PNA FISH assay, the
reference microbial strains listed in Table 1 were prepared in
physiological saline solution (bioMerieux) from fresh agar
culture and adjusted to deﬁned organism concentrations by
plate colony counting. Each PNA FISH probe set was tested in
duplicate with the corresponding microorganism suspensions
containing from 107 to 104 CFU/mL, which included the
detection limit declared by the manufacturer (105 CFU/mL). A
panel of 16 microbial strains served as negative controls in the
speciﬁcity testing.
Results
Analytical sensitivity and speciﬁcity of peptide nucleic acid
ﬂuorescence in situ hybridization
The detection limits for SA, EF, GNTL and YTL assays were
determined to be 106 CFU/mL by serial dilutions of positive
cultures.
The speciﬁcity of the probes used in the PNA FISH assays
was assessed by demonstrating the absence of ﬂuorescent
signal from all strains different to those recognized by the
molecular assay, except from Shigella sonnei, which cross-
reacted to create a green signal in the GNTL PNA FISH assay.
Conversely, a ﬂuorescent signal was obtained as expected
when the speciﬁc probes were used on the corresponding
reference strains.
Evaluation of peptide nucleic acid ﬂuorescence in situ
hybridization assays on blood cultures
Among the 921 positive blood samples submitted to PNA FISH
assays for bacteria detection, 860 samples (93.4%) contained
only one microorganism and 61 (6.6%) had mixed infections as
detected by MALDI-TOF MS applied to conventional cultures.
Out of the 860 samples with monomicrobial infections, 315
samples (36.6%) contained GNR and 545 (63.4%) GPC
(Table 2). The identiﬁcation obtained by the PNA FISH assays
was concordant, with regard to the species recognized by
PNA probes, with that obtained by MALDI-TOF MS from
conventional cultures in all samples, except in ﬁve cases
(99.4%): three samples containing GNR and negative to GNTL
and two samples containing GPC and positive for CNS by SA.
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As regards the three GNTL-negative cases, two were iden-
tiﬁed as P. aeruginosa and one as K. pneumoniae. In the other
two cases a red ﬂuorescence, referring to CNS, was produced
with isolates of Micrococcus luteus.
In 53 out of the 61 samples (87%) with mixed infections
(Table 3), PNA FISH assays gave concordant results with those
obtained by MALDI-TOF MS identiﬁcation for the species
recognized by PNA probes (10 GNR, 25 GPC and 18 GNR +
GPC). In the remaining eight samples (13%), PNA FISH failed
to reveal one of the species involved (two K. pneumoniae, one
E. coli and ﬁve Staphylococcus epidermidis).
The molecular identiﬁcation obtained by YTL for the 35
positive blood samples totally agreed with the culture-based
MALDI-TOF MS identiﬁcation (Table 4) with regard to the
species recognized by the PNA probes. In particular, the 26
samples positive for C. albicans/C. parapsilosis by PNA FISH
were identiﬁed as C. albicans in 22 cases (in one case in
association with C. glabrata) and as C. parapsilosis in four cases,
the eight samples positive for C. glabrata/C. krusei were
C. glabrata in six cases (in one case in association with
C. albicans) and C. krusei in two cases, and the sample positive
for C. tropicalis was conﬁrmed by MALDI-TOF MS. In the last
case, which was YTL-negative, MALDI-TOF MS identiﬁed
Candida lusitaniae, a species not included in the panel of PNA
probes.
Evaluation of peptide nucleic acid ﬂuorescence in situ
hybridization assay on cerebrospinal ﬂuid cultures
Nine out of the 11 samples of CSF submitted to PNA FISH
gave positive results: six CNS, one S. aureus, one K. pneumo-
niae and one E. coli. All PNA FISH results were in agreement
with those obtained by MALDI-TOF MS identiﬁcation. In the
remaining two samples, the PNA FISH assays gave negative
results as expected because the conventional culture method
identiﬁed one isolate of Streptococcus agalactiae and one of
Streptococcus parasanguinis, respectively.
Discussion
The PNA FISH technology, commercially available as a
diagnostic assay, represents a rapid (TAT 90 min) and reliable
technique for the identiﬁcation of the most frequent bacteria
and yeasts responsible for sepsis and provides faster identiﬁ-
cation than methods based on conventional culture.
In the present study, for the ﬁrst time to our knowledge, the
results of the PNA FISH assays are prospectively compared with
those obtained by the MALDI-TOF MS identiﬁcation applied to
conventional culture during a 1-year study in a large ter-
tiary-care setting. In our laboratory the workﬂow, the load and
the type of activity requires two MALDI-TOF MS instruments,
which complement each other in terms of analytical efﬁciency
for the different groups of microrganisms [24,25].
Regarding the performance of PNA FISH assays, the overall
identiﬁcation accuracy was 98.64% (ranging from 98.58% for
bacteria to 100% for yeasts), increasing to 99.4% when
considering monomicrobial infections.
Discordant results were observed in ﬁve samples with
monomicrobial infections (three GNR and two GPC) and in
eight samples with mixed infections. The production of a
TABLE 1. Reference bacterial and yeast strains used for determination of the PNA FISH detection limit and speciﬁcity testing
Micro organisms Origin Used for detection limit Used for speciﬁcity testing
Acinetobacter haemolyticus NEQAS 8539 – GNTL
Candida albicans ATCC 24433 YTL –
Candida dubliniensis NEQAS 9463 – YTL
Candida glabrata NEQAS 0142 YTL –
Candida kefyr ATCC Y050 YTL YTL
Candida krusei ATCC 62589 YTL –
Candida lusitaniae NEQAS 8863 – YTL
Candida parapsilosis ATCC 22019 YTL –
Candida tropicalis ATCC 750 YTL –
Enterococcus casseliﬂavus ATCC 700327 EF SA
Enterococcus faecalis ATCC 51299 EF SA
Escherichia coli ATCC 25922 GNTL –
Haemophilus inﬂuenzae NEQAS 9531 – GNTL
Klebsiella pneumoniae ATCC 700603 GNTL –
Listeria monocytogenes NEQAS 9483 – GNTL, SA, EF
Neisseria gonorrhoeae NEQAS 9928 – GNTL
Pseudomonas aeruginosa ATCC 27853 GNTL –
Saccharomyces cerevisiae NEQAS 9005 – YTL
Serratia marcescens NEQAS 8859 – GNTL
Shigella sonnei ATCC 25931 – GNTL
Staphylococcus aureus ATCC 29213 SA EF
Staphylococcus epidermidis Clinical isolatea SA –
Streptococcus agalactiae ATCC 12386 – SA, EF
Streptococcus pneumoniae NEQAS 8886 – SA, EF
Trichosporon mucoides ATCC 204096 – YTL
ATCC, American Type Culture Collection; NEQAS, National External Quality Assessment Service, United Kingdom; GNTL, ‘GNR Trafﬁc Light PNA FISH’; PNA FISH, peptide
nucleic acid ﬂuorescence in situ hybridization; YTL, ‘Yeasts Trafﬁc Light PNA FISH’; EF, ‘E. faecalis/OE PNA FISH’; SA, ‘S. aureus/CNS PNA FISH’.
aIdentiﬁed by conventional biochemical proﬁle using the Vitek 2 System (bioMerieux).
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bacterial capsule in two strains (1 K. pneumoniae and 1
P. aeruginosa) and point mutations in the organism rRNA
sequence could explain the negative results by GNTL [1,22].
The two positive samples for CNS by SA contained M. luteus,
which was even misidentiﬁed as S. aureus by other authors
[26]; an explanation could be the strict correlation between
M. luteus and Staphylococcus spp. For these discordant results
MALDI-TOF MS identiﬁcation was conﬁrmed by conventional
biochemical methods (data not shown).
The failure to correctly identify the species contained in
the eight samples with mixed infections may be due to the
lower detection limit of the culture-based method compared
with that of the PNA FISH. In our hands, PNA FISH
demonstrated a detection limit of 106 CFU/mL, which is
consistent with the analytical sensitivity of the slide-based
staining techniques. The PNA FISH assays allowed us to
identify bacteria and yeasts 1.3 days before the MALDI-
TOF MS identiﬁcation and 2 days earlier in the case of
polymicrobial infections.
In the light of the good results obtained using the PNA FISH
assays on positive BCs, we extended this assay to CSF
cultures. The results of the PNA FISH assays totally agreed
with those obtained by MALDI-TOF MS from conventional
cultures, providing a useful identiﬁcation with a TAT reduction
of 1.1 days. The use of PNA FISH with clinical samples other
than blood seems a promising approach, especially for those




Conventional identiﬁcation by matrix-assisted
laser desorption/ionization-time of ﬂight







rods (n = 315)
177 44 18 76 315
E. coli (ESBL n = 10) 177 177
K. pneumoniae (ESBL n = 3) 44 1 45
P. aeruginosa 18 2 20
Acinetobacter baumannii, A. junii, A. calcoaceticus, A. lwoﬁi 11 11
Aeromonas caviae 1 1
Bacteroides distasonis, B. fragilis, B. ovatus 8 8
Campylobacter coli, C. jejuni 2 2
Citrobacter freundii, C. koseri 3 3
Clostridium symbiosuma 1 1
Enterobacter aerogenes, E. agglomerans, E. cloacae 16 16
Fusobacterium necrophorum 1 1
Klebsiella oxytoca 6 6
Proteus mirabilis, P. vulgaris 7 7
Pseudomonas luteola, P. oryzihabitans, P. putida,
P. putrefaciens, Pseudomonas sp.
5 5
Salmonella enterica group B, S. Panama, S. Paratyphi A 6 6
Serratia marcescens 4 4
Sphingobacterium spiritivorum 1 1








cocci (n = 545)
108 351 27 15 44 545
S. aureus (MRSA n = 9) 108 108
E. faecalis 27 27
Enterococcus faecium 15 15
Leuconostoc pseudomesenteroides 1 1
Micrococcus luteus 2 5 7
Peptostreptococcus parvulus 1 1
Staphylococcus auricularis 2 2
Staphylococcus capitis 32 32
Staphylococcus epidermidis 181 181
Staphylococcus haemolyticus 28 28
Staphylococcus hominis 93 93
Staphylococcus saccharolyticus 3 3
Staphylococcus saprophyticus 2 2
Staphylococcus schleiferi 1 1
Staphylococcus warneri 4 4
Staphylococcus xylosus 3 3
Streptococcus agalactiae 7 7
Streptococcus anginosus 2 2
Streptococcus constellatus 2 2
Streptococcus gallolyticus 3 3
Streptococcus gordonii 2 2
Streptococcus mitis, S. infantarius, S. salivarius 9 9
Streptococcus pneumoniae 11 11
Streptococcus pyogenes 1 1
ESBL (extended spectrum beta-lactamase) and MRSA (methicillin-resistant Staphylococcus aureus) were identiﬁed by antimicrobial susceptibility testing.
CNS, coagulase-negative staphylococci.
aMisidentiﬁed by Gram stain.
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TABLE 3. Peptide nucleic acid ﬂuorescence in situ hybridization (PNA FISH) results for 61 positive blood samples with
polymicrobial infections
Gram stain microscopy
Conventional identiﬁcation by matrix-assisted
laser desorption/ionization-time of ﬂight
PNA FISH assay results
Expected Not expected
Gram-negative rods (n = 13) 10 3
Enterobacter cloacae+ Klebsiella oxytoca+ Proteus mirabilis 1
Escherichia coli+ Aeromonas caviae 1
E. coli+E. cloacae 2
E. coli+Klebsiella pneumoniae 2 2a
E. coli+Pseudomonas aeruginosa+Bacteroides fragilis 1
K. pneumoniae+Aeromonas hydrophila 1b
K. pneumoniae+B. fragilis 1
K. pneumoniae+Citrobacter koseri 1
K. pneumoniae+K. oxytoca+E. cloacae 1
Gram-positive cocci (n = 30) 25 5
Streptococcus parasanguinis+Actinomyces viscosus 1
Streptococcus mitis+ Lactobacillus rhamnosus 1
Staphylococcus hominis+ Streptococcus pneumoniae 1
Staphylococcus epidermidis+ Staphylococcus xylosus 1
S. epidermidis+Staphylococcus schleiferi 1
S. epidermidis+S. hominis 3
S. epidermidis+Staphylococcus cohnii ssp. urealyticus 1
S. epidermidis+Staphylococcus capitis 2
S. epidermidis+Streptococcus anginosus 1c
S. epidermidis+Pediococcus acidilactici 1
Staphylococcus aureus+Staphylococcus haemolyticus 1
S. aureus+Streptococcus agalactiae 1
S. aureus (MRSA)+S. capitis 1
Enterococcus faecium+S. haemolyticus 1
E. faecium+S. epidermidis 2
Enterococcus faecalis+S. hominis 1
E. faecalis+S. haemolyticus 1
E. faecalis+S. epidermidis 1 4c
E. faecalis+S. aureus 2
E. faecalis+E. faecium+Staphylococcus caprae 1
E. faecalis+E. faecium 1
Gram-negative rods and Gram-positive cocci (n = 18) 18 0
E. coli+E. faecalis+C. koseri 1
E. faecalis+K. pneumoniae 1
E. faecium+E. coli 1
E. coli+E. faecium+P. mirabilis+K. oxytoca 1
S. aureus+E. coli 1
K. pneumoniae+ S. epidermidis 2
S. epidermidis+Salmonella enterica group B 1
S. epidermidis+Salmonella Typhimurium 1
S. epidermidis+P. mirabilis 1
S. epidermidis+ Stenotrophomonas maltophilia 1
E. coli+ S. epidermidis 1
E. faecalis+E. cloacae 1
E. faecium+E. coli (ESBL) 1
E. coli+ S. mitis 1
E. coli+K. pneumoniae+ Streptococcus gallolyticus 1
S. epidermidis+ Acinetobacter baumannii 1
K. pneumoniae+ S. aureus 1
Total 53 8
aOne K. pneumoniae and one E. coli were not identiﬁed by PNA FISH.
bK. pneumoniae was not identiﬁed by PNA FISH.
cS. epidermidis was not identiﬁed by PNA FISH; ESBL (extended spectrum beta-lactamase) and MRSA (methicillin-resistant S. aureus) were identiﬁed by antimicrobial susceptibility
testing.
TABLE 4. Peptide nucleic acid ﬂuorescence in situ hybridization (PNA FISH) results for 35 blood samples positive for yeasts
Gram stain
microscopy
Conventional identiﬁcation by matrix-assisted laser
desorption/ionization-time of ﬂight mass spectrometry









26 8 1 1 36
C. albicans 21 21
C. parapsilosis 4 4
C. glabrata 5 5
C. krusei 2 2
C. tropicalis 1 1
Candida lusitaniae 1 1
C. albicans + C. glabrata 1a 1a 2a
aOne was a mixed infection, C. albicans and C. glabrata.
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samples, submitted in parallel with conventional solid culture
and automated liquid culture [27], for which only the latter
method gives a positive result.
These data demonstrate that the use of PNA FISH assays in
tertiary-care hospitals may improve the laboratory diagnosis of
sepsis by identifying or by ruling out certain infections in a
shorter period of time as compared with culture-based
MALDI-TOF MS identiﬁcation.
With a further reduction in the TAT of the new-generation
PNA FISH technology (QuickFISH assays, based on a 15-min
hybridization without washing/mounting steps) and extension
of the panel of probes, including other species or resistance
markers, such as those for MRSA and ESBL Enterobacteriaceae,
PNA FISH will become a very useful tool in the diagnosis of
bloodstream infections [8,26]. Although innovative applications
of MALDI-TOF MS have been proposed to identify nearly all
the bacteria and yeasts involved in human infections [6,9],
most of the recovery protocols for the direct identiﬁcation by
MALDI-TOF are cumbersome and suffer from variable iden-
tiﬁcation rates and concordance with conventional identiﬁca-
tion methods [6,9,28–30].
Even if MALDI-TOF MS directly applied to positive blood
bottles is cheaper than PNA FISH (about €3 vs. €40, VAT
excluded), it requires expensive instrumentation, a better
evaluation in clinical settings and is not useful in the case of
mixed infections. For these reasons, although PNA FISH has a
limited spectrum of recognized species, it remains at present a
quick and easy-to-perform method, which requires only basic
laboratory equipment, and the results of this study suggest its
usefulness in the case of mixed infections.
The reduction in time to result represents one of the main
advantages of the PNA FISH technology, which could affect
antibiotic and antifungal utilization, allowing for more targeted
and shorter therapy [7], increased beneﬁts for patients and
overall reduction of healthcare costs.
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